MANCHESTER EVENING NEWS: Skin health company to develop and commercialise its probiotic technology

Press/Media: Other

Description

A skin health specialist, which raised £4.5m when it listed on the London stock market last week, will use the funds to drive forward its probiotic technology for skin health applications.

SkinBioTherapeutics, a University of Manchester spin-out, will focus on developing and commercialising its SkinBiotix technology platform.

Period11 Apr 2017

Media coverage

1

Media coverage

  • TitleSkin health company to develop and commercialise its probiotic technology
    Media name/outletThe Manchester Evening News
    Media typeWeb
    Country/TerritoryUnited Kingdom
    Date11/04/17
    DescriptionA skin health specialist, which raised £4.5m when it listed on the London stock market last week, will use the funds to drive forward its probiotic technology for skin health applications.

    SkinBioTherapeutics, a University of Manchester spin-out, will focus on developing and commercialising its SkinBiotix technology platform.
    URLwww.manchestereveningnews.co.uk/business/business-news/skin-health-company-develop-commercialise-12874121
    PersonsCatherine O'Neill, Andrew Mcbain
View all 1
View less

Keywords

  • skin
  • spinout companies
  • pharmaceuticals

Related content